AUB ScholarWorks

Browsing Experimental Pathology, Microbiology, and Immunology by Subject "Zanamivir"

Browsing Experimental Pathology, Microbiology, and Immunology by Subject "Zanamivir"

Sort by: Order: Results:

  • Burden of influenza B virus infection and considerations for clinical management 
    Zaraket, Hassan; Hurt, Aeron C.; Clinch, Barry; Barr, Ian George; Lee, Nelson L.S. (Elsevier B.V., 2021)
    Influenza B viruses cause significant morbidity and mortality, particularly in children, but the awareness of their impact is often less than influenza A viruses partly due to their lack of pandemic potential. Here, we ...
  • Characterization of human influenza viruses in lebanon during 2010-2011 and 2011-2012 post-pandemic seasons 
    Zaraket, Hassan; Dapat, Clyde P.; Ghanem, Soha T.; Ali, Zainab; Lteif, Mireille; Kondo, Hiroshi; Dapat, Isolde Caperig; Saito, Kousuke; Kayali, Ghazi; Suzuki, Hiroshi; Dbaibo, Ghassan S.; Saito, Reiko (S. Karger AG, 2014)
    Objective: To genetically characterize human influenza viruses and their susceptibilities to antivirals during two post-pandemic seasons in Lebanon.; Methods: Influenza virus was isolated from nasopharyngeal swabs that ...
  • Characterization of influenza outbreaks in Lebanon during the 2013/14 and 2014/15 seasons 
    Saito, Reiko; Akinobu, H.; Shaker, Rouba A.; Akel, Imad S.; Assaf-Casals, Aia; Lteif, Mireille; Odagiri, Takashi; Inaba, R.; Soudani, Nadia Y.; Khafaja, Sarah A.; Ghanem, Soha T.; Rajab, Mariam El; Shobugawa, Yugo; Dbaibo, Ghassan S.; Zaraket, Hassan (World Health Organization, 2016)
    Despite the significant burden of influenza outbreaks, active disease monitoring has been largely absent in the Middle East, including Lebanon. In this study we characterized influenza virus in 440 nasopharyngeal swabs ...
  • Peramivir: A novel intravenous neuraminidase inhibitor for treatment of acute influenza infections 
    Alame, Malak M.; Massaad, Elie; Zaraket, Hassan (Frontiers Media S.A., 2016)
    Peramivir is a novel cyclopentane neuraminidase inhibitor of influenza virus. It was approved by the Food and Drug Administration in December 2014 for treatment of acute uncomplicated influenza in patients 18 years and ...

Search AUB ScholarWorks


Browse

My Account